Government Strengthens financial assistance for Loan Schemes for Entrepreneurs, Farmers, Small Businesses and startups PMMY Offers Collateral-Free Loans for Small Businesses across Four Categories
New Loan Scheme for first-Time Entrepreneurs announced in Union Budget 2025-26
In Union Budget 2025-26, the government raised MISS loan limit for KCC borrowers from ₹3 lakh to ₹5 lakh
Jan Samarth Portal: One-Stop Digital Platform for Easy access to 15 Government Loan Schemes
Posted On: 25 MAR 2025 5:48PM by PIB Delhi
The Government runs many credit Schemes for small traders, farmers and startups. The details of few of these schemes are mentioned below.
It provides collateral-free institutional credit through Member Lending Institutions (MLIs) i.e. Scheduled Commercial Banks (SCBs), Regional Rural Banks (RRBs), Non-Banking Financial Companies (NBFCs) and Micro Finance Institutions (MFIs).
Any individual, who is otherwise eligible to take a loan and has a business plan can avail loan under the Scheme. The loan is available for income generating activities in the manufacturing, trading, services sector and also for activities allied to agriculture across four loan products, viz. Shishu (loans up to Rs. 50,000), Kishore (loans above Rs. 50,000 and up to Rs. 5 lakh) and Tarun (loans above Rs. 5 lakh and up to Rs. 10 lakh). Loans upto Rs. 20 lakh under Tarun Plus category are given to those entrepreneurs who have availed and successfully repaid previous loans under the ‘Tarun’ category.
The objective of the Scheme is to facilitate loans from Scheduled Commercial Banks (SCBs) of value between Rs. 10 lakh and Rs. 1 crore to at least one Scheduled Caste (SC) or Scheduled Tribe (ST) borrower and one Woman borrower per bank branch for setting up greenfield enterprise in manufacturing, services or trading sector, including activities allied to agriculture.
Under both the Schemes, the prospective borrowers may avail the loan for trading, activities allied to agriculture and for new business.
As per para 32 of Union Budget 2025-26 “A new scheme will be launched for 5 lakh women, Scheduled Castes and Scheduled Tribes first- time entrepreneurs. This will provide term loans upto Rs.2.00 crore during next 5 years. The Scheme will incorporate lessons from successful Stand Up India Scheme. Online capacity building for entrepreneurship and managerial skills will also be organized.”
Kisan Credit Card (KCC), introduced in 1998, is a banking product that provides farmers with timely and affordable credit for purchasing agricultural inputs such as seeds, fertilizers, and pesticides, as well as for meeting cash requirements related to crop production and allied activities. In 2019, the KCC scheme was extended to cover the working capital requirements of allied activities, viz. Animal Husbandry, Dairy and Fisheries.
Government of India under Modified Interest Subvention Scheme provides Interest Subvention of 1.5% to banks for providing short-term working capital loans upto Rs. 3 lakh at 7% p.a. Further, a Prompt Repayment Incentive of 3% is also provided to farmers on timely repayment of loans. Therefore, effective interest rate for farmers is 4%. In the Union Budget 2025-26, the Government has announced to enhance loan limit under the MISS from Rs. 3 lakh to Rs. 5 lakh for loans taken through the KCC.
The Jan Samarth portal is a one-stop digital platform for linking fifteen Government-sponsored loans and subsidies Schemes. It provides a quick and efficient way to apply for loans and obtain approvals based on a digital evaluation of the applicant’s data. Further, many Banks and financial institutions have developed online platforms and mobile apps for end to end digital processing of loan applications, reducing the need for physical paperwork and in-person visits.
This information was given by Minister of State in the Ministry of Finance Shri Pankaj Chaudhary written reply to a question in Rajya Sabha today.
In the year 2018-19, Government of India has extended the facility of Kisan Credit Card to fishers and fish farmers to meet their working capital requirements. Under the scheme, farmers receive KCC loans up to Rs.2.00 Lakhs (fishers & fish farmers) at a subsidized interest rate of 7%. To facilitate this, an up-front interest subvention (IS) of 1.5% is provided to financial institutions by the Govt. of India and additionally, farmers who repay their loans promptly on time, receive a 3% Prompt Repayment Incentive (PRI), effectively reducing the interest rate to 4% per annum. Besides, the collateral-free loan limit for KCC fisheries has also been enhanced from Rs.1.60 lakh to Rs. 2.00 lakh from 01.01.2025. Moreover, in the Union Budget 2025-26, the Government of India has increased the Kisan Credit Card (KCC) lending limit of loans up to ₹5 lakh to enhance credit accessibility for fishers, farmers, processors and other fisheries stakeholders under the Modified Interest Subvention Scheme. Till date, 4,63,492 KCC cards have been issued to fishers and fish farmers with a loan amount of Rs. 2982.58 crore in all States/UTs.
Besides, the Department of Fisheries, Ministry of Fisheries, Animal Husbandry and Dairying, with effect from financial year 2018-19 is implementing Fisheries and Aquaculture Infrastructure Development Fund (FIDF) with a total fund size of Rs 7522.48 crore. FIDFinter-aliaprovides concessional finance for development of various fisheries infrastructure facilities to the Eligible Entities (EEs), including State Governments/Union Territories, State entities and other Stakeholders for development of identified fisheries infrastructure facilities. Under FIDF, the Department of Fisheries provides interest subvention up to 3% per annum for providing the concessional finance by the NLEs at the interest rate not lower than 5% per annum. A total of 141 projects with outlay of Rs.3947.54 crore have been approved under FIDF.
Further, in order to provide social security measure to fishers, the Department of Fisheries, Ministry of Fisheries, Animal Husbandry and Dairying, Government of India under ongoing Pradhan Mantri Matsya Sampada Yojana (PMMSY) provides Group accidental insurance coverage to fishers wherein the entire insurance premium amount is borne by the Central and State Government, with no contribution from the beneficiary. The insurance coverage provided includes (i) Rs.5,00,000/- against death or permanent total disability, (ii) Rs.2,50,000/- for permanent partial disability and (iii) hospitalization expenses in the event of accident for a sum of Rs. 25,000/. During the last three years (2021-22 to 2023-24) and current financial year (2024-25) of the implementation of the PMMSY,131.30 lakh fishers with an average of 32.82 lakh fishers annually have been enrolled for providing insurance coverage under the Scheme.
This information was given by Union Minister of State, Ministry of Fisheries, Animal Husbandry and Dairying, Shri George Kurian, in a written reply in Lok Sabha on 25th March, 2025.
Global CEO of Eli Lilly, world’s pioneer Insulin manufacturing Company, David Ricks called on Union Minister Dr. Jitendra Singh to discuss strengthening partnership, with a focus on Insulin and Non-Communicable Disease (NCD) therapies as well as biomanufacturing The talks also covered the establishment of a Centre of Excellence for insulin therapies, as well as clinical trials for advanced treatment options
Posted On: 25 MAR 2025 5:47PM by PIB Delhi
Global CEO of Eli Lilly, world’s pioneer Insulin manufacturing Company, David Ricks called on Union Minister of State (Independent Charge) for Science and Technology; Earth Sciences and Minister of State for PMO, Department of Atomic Energy, Department of Space, Personnel, Public Grievances and Pensions, Dr. Jitendra Singh to discuss strengthening partnership, with a focus on Insulin and Non-Communicable Disease (NCD) therapies as well as biomanufacturing.
Eli Lilly, a global pharmaceutical giant headquartered in Indianapolis, Indiana and a global pioneer in Insulin production for Diabetes and several other drugs particularly for Cancer etc has a significant presence in India through its subsidiary, Eli Lilly and Company (India) Pvt. Ltd. The company imports and markets medicines for diabetes, gastric cancer, lung cancer, breast cancer, osteoporosis, rheumatoid arthritis, and other critical diseases. Its operations also extend to Nepal, Bangladesh, and Sri Lanka through partnerships with local pharmaceutical firms.
The talks also covered the establishment of a Centre of Excellence for insulin therapies, as well as clinical trials for advanced treatment options.
Dr. Jitendra Singh, himself a renowned Endocrinologist, emphasized on carrying out studies particularly for India, as there is difference in metabolic disorders faced in India and the rest part of the world. He stressed that food habits and phenotype are different thus central obesity and visceral obesity is quite prevalent.
With diabetes being a major health concern in India, discussions on expanding insulin production and accessibility hold immense significance. Dr. Jitendra Singh, who has been vocal about leveraging biotechnology for affordable healthcare solutions, welcomed the dialogue, emphasizing India’s growing capabilities in pharmaceuticals and clinical research. The conversation aligns with the government’s broader push for self-reliance in drug manufacturing and innovation in life sciences.
Referring to India’s push for affordable healthcare for all and the importance of generic medicine, Dr. Jitendra Singh said “Both Generic Medicine and advancement in specialized medicine can co-exist in India.
Eli Lilly’s engagement aligns with the government’s broader vision of achieving self-reliance in drug manufacturing and advancing innovation in life sciences. Dr. Jitendra Singh has emphasized that bio-manufacturing plays a crucial role in India’s Atmanirbhar Bharat initiative by reducing import dependence and ensuring wider access to cutting-edge therapies. He has pointed out that India’s robust pharmaceutical industry, evolving biotech ecosystem, and highly skilled scientific workforce position the country as a potential global leader in bio-manufacturing. The Minister has also highlighted the importance of government-industry collaboration in accelerating research, streamlining regulatory processes, and driving innovation, particularly in insulin production and treatments for non-communicable diseases.
Eli Lilly’s engagement with India comes at a time when the country is focusing on bolstering its pharmaceutical industry, not just for domestic needs but also as a global supplier. The potential establishment of a Centre of Excellence could serve as a critical step in making insulin therapies more accessible, reinforcing India’s role in combating lifestyle diseases.
The meeting underscores the increasing collaboration between global pharmaceutical firms and the Indian government, with a shared vision of enhancing healthcare accessibility and advancing research in non-communicable diseases.
The Telecom Regulatory Authority of India (TRAI) has today issued its response to the back-reference received from Department of Telecommunications (DoT) in respect of TRAI’s recommendations dated 24.04.2024 on‘Telecommunication Infrastructure Sharing, Spectrum Sharing, and Spectrum Leasing’.
Earlier, DoT, through a reference dated 07.12.2021 under Section 11 (1) (a) of the TRAl Act, 1997, requested TRAI to provide recommendations on allowing sharing of core network elements such as MSC, HLR, IN etc., among telecom operators. Subsequently, DoT, through a reference dated 10.02.2022, mentioning its earlier reference dated 07.12.2021, informed that “to promote optimum resource utilization among the licensees, it is proposed to allow sharing of all kinds of telecom infrastructure and network elements among all categories of service providers licensed under the Section 4 of Indian Telegraph Act, 1885 for provision of authorized telecom services”, and requested TRAI to provide recommendations on the subject.
Considering the request of stakeholders to permit inter-band spectrum sharing and leasing of spectrum in the country, the Authority decided to take up the issues related to spectrum sharing and spectrum leasing along with the issues related to infrastructure sharing in the stakeholders’ consultation.
After a comprehensive consultation with stakeholders, TRAI sent its recommendations on ‘Telecommunication Infrastructure Sharing, Spectrum Sharing, and Spectrum Leasing’ to DoT on 24.04.2024.
Subsequently, DoT, through a back-reference dated 13.02.2025, informed TRAI that as per Section 11(1) of the TRAI Act 1997 (as amended), such recommendations on ‘Telecommunication Infrastructure Sharing, Spectrum Sharing, and Spectrum Leasing’ dated 24.04.2024, where the Government has reached aprima-facieconclusion that these recommendations may not be accepted or may need modification are being referred back to TRAI for its reconsideration.
In this regard, after a careful examination, TRAI has sent its response to the back-reference to DoT. TRAI’s response to the back-reference has also been placed on the TRAI’s website (www.trai.gov.in).
For any clarification or information, Shri Akhilesh Kumar Trivedi, Advisor (Networks, Spectrum and Licensing), TRAI may be contacted at Telephone Number +91-11-20907758.
The uniform ban on fishing for 61 days is implemented annually by the Department of Fisheries, Government of India in the Exclusive Economic Zone (EEZ) of India beyond territorial waters on both the coasts for 61 days (i.e., 15th April to 14th June in the East Coast, and 1st June to 31st July in the West Coast) based on the recommendations of the Technical Committee and in consultation with the coastal States/Union Territories (UTs). The traditional non-motorized units are exempted from this uniform fishing ban imposed in the Indian EEZ beyond territorial waters. Similarly, the coastal States/UTs are also implementing the fishing ban within their territorial waters in line with the uniform ban implemented in the EEZ. Under the Pradhan Mantri Matsya Sampada Yojana (PMMSY) implemented by the Department of Fisheries, Government of India, the livelihood and nutritional support for socio-economically backward active traditional fishers is provided during the fishing ban/lean period. Livelihood and nutritional support for 5,97,709 fisher families has been provided annually during fishing ban/lean period, at a total investment of Rs.1059.94 crores during 2020-21 to 2023-24.
As informed by the Department of Commerce, Ministry of Commerce and Industry, Govt. of India, there has been an import of fish and fish products worth 722.01 million USD to India in the last 3 years (FY 2021-22 to FY 2023-24), including import in the state of Tamil Nadu. As informed by the Marine Products Export Development Authority (MPEDA) under the Department of Commerce, Ministry of Commerce and Industry, there has been an export of fish and fish products worth 23,235.78 million USD from India in the last 3 years (FY 2021-22 to FY 2023-24), including fish and fish products worth 2,607.99 million USD from the state of Tamil Nadu.
In order to promote the export of marine products, the Department of Fisheries, Government of India has taken several steps, these inter-alia include support through PMMSY for branding, standards and certification, training and capacity building, creation of post-harvest infrastructure with emphasis on seamless cold-chain and development of modern fishing harbours and fish landing centers, etc. In addition, to address the critical infrastructure requirements of fisheries and aquaculture sectors, the Department of Fisheries, GoI during 2018-19 has created the Fisheries and Aquaculture Infrastructure Development Fund (FIDF) with a total fund size of Rs 7522.48 crore to provide concessional finance to states/UT and private sector. In this regard the supported activities included development of 27,823 ice plant /cold storages and transportation facilities with an investment of ₹1362 Cr, acquisition of 1398 Deep Sea Fishing Vessels (₹ 1310 Cr) and up-gradation of 1338 fishing vessels (₹ 193.64 Cr). Further, Department of Fisheries has also approved the projects for export oriented fish species such as Scampi, Mud crab, Asian Seabass, Cobia etc. and supported the state-of-the-art aquaculture production technologies like RAS and Biofloc. In addition, Department of Fisheries, GoI has notified Tuna Cluster in the Union Territory of Andaman & Nicobar Islands, Seaweed Cluster in the Lakshadweep and has issued the Guidelines for promoting diversified species and Nucleus Breeding Centre (NBCs)/Broodstock Multiplication Centre (BMCs) under the Coastal Aquaculture Authority Act, 2005 (amended in 2023). Apart from this, to ensure the sustainability and uninterrupted supply of Indian seafood material to the US Market, the Department is supporting a Marine Mammal Stock Assessment Project at the cost of around ₹ 13.29 Cr. In order to meet the requirements of the export markets for wild-caught shrimp, the Department of Fisheries is facilitating the installation of Turtle Excluder Devices (TEDs) in shrimp trawlers by including TEDs as a separate line item under the PMMSY scheme, and has advised the maritime states/UTs to mandate TED usage in trawl nets through amendments in their respective Marine Fisheries Regulation Acts. To strengthen India’s seafood sector globally, the Government is facilitating ease of business by amending Coastal Aquaculture Authority Act (Amendment) 2023. In addition, the Department is conducting Investors meets, Stakeholders consultation and also advising the States/UTs to encourage the farmers to attend the technical and demonstration workshops/training programs related to seed and feed, technology infusion, ornamental fisheries, hatchery technologies etc. on periodic basis in order to increase in productivity and quality of fishery produce.
This information was given by Union Minister of State, Ministry of Fisheries, Animal Husbandry and Dairying, Shri George Kurian, in a written reply in Lok Sabha on 25th March, 2025.
Union Home Minister and Minister of Cooperation, Shri Amit Shah says separatism has become history in Kashmir A big victory for Prime Minister Shri Narendra Modi Ji’s vision of building a developed, peaceful and unified Bharat
The unifying policies of the Modi government have tossed separatism out of J&K
Two organizations associated with the Hurriyat announced the severing of all ties with separatism
Posted On: 25 MAR 2025 5:43PM by PIB Delhi
Union Home Minister and Minister of Cooperation, Shri Amit Shah has said that separatism has become history in Kashmir.
In his post on X platform Home Minister said, the unifying policies of the Modi government have tossed separatism out of J&K. Two organizations associated with the Hurriyat have announced the severing of all ties with separatism.
Shri Amit Shah said that he welcomes this step towards strengthening Bharat’s unity and urge all such groups to come forward and shed separatism once and for all. Union Home Minister and Minister of Cooperation said that it is a big victory for Prime Minister Shri Narendra Modi Ji’s vision of building a developed, peaceful and unified Bharat.
Separatism has become history in Kashmir.
The unifying policies of the Modi government have tossed separatism out of J&K. Two organizations associated with the Hurriyat have announced the severing of all ties with separatism.
I welcome this step towards strengthening Bharat’s…
Ministry of Fisheries, Animal Husbandry & Dairying
Aquaculture and Marine Export
Posted On: 25 MAR 2025 5:42PM by PIB Delhi
The Government of India, Ministry of Commerce and Industry has established the Marine Products Export Development Authority (MPEDA) as a dedicated agency to facilitate export of seafood. MPEDA, through its field offices in maritime States and registered societies like NaCSA (National Centre for Sustainable Aquaculture), NETFISH (Network for Fish Quality Management & Sustainable Fishing) and RGCA (Rajiv Gandhi Centre for Aquaculture) is taking various activities to promote sustainable aquaculture and marine exports. In aquaculture, MPEDA focused on capacity building for better management practices, antibiotic reduction through initiatives like “SHAPHARI” certification and ELISA labs, and disease control through Aqua One Centres and mobile labs. MPEDA also supported sustainable shrimp farming through NaCSA and operated seven technology transfer projects via RGCA. In the marine sector, MPEDA, primarily through NETFISH, conducted workshops and trials for Turtle Excluder Device (TED) implementation, supported marine mammal stock assessments for US Marine Mammal Protection Act (MMPA) compliance, promoted eco-friendly fishing gear like square mesh cod ends, and organized numerous coastal clean-up drives and plastic collection projects and hands-on training programs and meets. The details of these projects and their outcomes, project-wise is furnished as Annexure-I and II.
MPEDA has implemented several measures to promote environmentally sustainable shrimp farming by encouraging eco-friendly practices, responsible resource management, and disease prevention strategies. MPEDA also ensure quality and traceability through farm/hatchery enrollment and SHAPHARI certification programs, which include geographical mapping and unique identification numbers. MPEDA supports infrastructure development by providing financial assistance for nursery-rearing units and shrimp handling centers, all aimed at enhancing sustainable practices and ensuring high-quality, safe shrimp production for export. Additionally, through various training programs, MPEDA promote sustainable shrimp farming. With regard to seaweed cultivation, MPEDA-RGCA signed MoU with Department of Fisheries and Fisheries Welfare, Government of Tamil Nadu for supplying the quality germplasm of seaweeds and technical consultant for establishment of Multipurpose Seaweed Aqua Park under Pradhan Mantri Matsya Sampda Yojana (PMMSY) assistance.
Annexure-I
Aquaculture and Marine Export.
Sl.No.
Name of the project
Name of the produce/ services
No. of Beneficiaries
Quantity supplied
1
Asian Seabass Hatchery, Thoduvai, Tamil Nadu
Seabass fingerlings (nos.)
4300
49.8 million
2
Mud crab Hatchery,
Thoduvai, Tamil Nadu
Crab instar (nos.)
919
11.27 million
3
GIFT Tilapia Hatchery
Vijayawada, Andra Pradesh
GIFT seed (nos.)
581
50.48 million
GIFT brood-fry (nos.)
50
84,295
4
Marine Finfish Hatchery,
Pozhiyoor, Kerala
Cobia fingerlings (nos.)
95
1,25,091
Pompano (nos)
115
5,02,250
5
Aquatic Quarantine Facilities for
L. vannamei, Chennai, Tamil Nadu
L. vannamei Broodstocks (nos.) quarantined
4,175
25,26,607
P. monodon broodstocks (nos.) quarantined
28,128
P. monodon PPLs (nos.) quarantined
1,84,077
L. vannamei PPLs (nos.)
9,19,431
6
Artemia Demo Farm at
Tharuvaikulam&Uppoor, Tamil Nadu
Artemia biomass (kg)
725
9400
Artemia cyst (tins)
4,673
7
Multispecies Aquaculture Complex (MAC)
Vallarpadam, Kerala
GIFT Seed (nos.)
8,704
15.68 million
Seabass fingerlings (nos.)
1,484
14,12,018
Etroplus suratensis seed (nos.)
690
12,12,425
P. monodon seed (nos.)
185
89,69,455
Contribution from RGCA Central Laboratories
S.No
Laboratory
Testing (by samples)
Samples
(Nos)
No. of Beneficiaries
1
Mobile Aquaculture Disease Diagnosis Laboratory
Molecular diseases diagnosis (PCR)
4,570
1,094
Microbiology & water parameters
2
Central Aquaculture Pathology Laboratory
Molecular diseases diagnosis (PCR), Microbiology & water parameters,Histology
Disease surveillance / NSPAAD,
Seed health, PCR-based species identification,Sequencing-based species identification
30,635
4,532
3
Central Aquaculture Genetics Laboratory
24,897
555
Annexure-II
Aquaculture and Marine Export.
Sl.No.
Hands on Training Program/ Meets
No. of Trainings/ Events
No. of Beneficiaries
1
Best Management Practices of nursery, grow-out and cage culture in earthen ponds for Asian Seabass
95
1,814
2
Best Management Practices of nursery, grow-out and Softshell culture of Mangrove Mud crab
106
1,909
3
Breeding, Seed Production and Grow – out farming of Genetically Improved Farmed Tilapia (GIFT)
79
1,165
4
Artificial Insemination Technique used for SPF Black Tiger Shrimp, Penaeus monodon with special reference to Broodstock Management, Maturation and Seed Production
4
22
5
Hatchery Production of Marine Finfish
2
3
6
Artemia Production & Processing of Cyst and Biomass
8
265
7
PCR and its Application in Aquaculture Pathology
44
945
8
PCR and its Application in Aquaculture Genetics Research
37
773
9
RAS ( Re-circulatory Aquaculture System)
1
23
10
Training at MAC, Vallarpadam
13
203
11
Farmers Meet/ Program for SC/ST beneficiaries:
on Diversified Aquaculture/
558
17563
This information was given by Union Minister of State, Ministry of Fisheries, Animal Husbandry and Dairying, Shri George Kurian, in a written reply in Lok Sabha on 25th March, 2025.
Revolutionizing Mobility The Make in India Auto Story
Posted On: 25 MAR 2025 5:39PM by PIB Delhi
Key Takeaways
Make in Indiahas boosted domestic car production and EV manufacturing.
The automobile sector contributes approximately 6%to India’s national GDP
Vehicle productiongrew from 2 million (1991-92) to 28 million (2023-24).
Automobile exportsreached 4.5 million units in FY 2023-24.
US $36 billion FDIattracted in the past four years.
4.4 million EVs registered, with 6.6% market penetration.
PLI & PM E-DRIVE schemessupporting EV and battery manufacturing.
GST on EVs reducedfrom 12% to 5%.
India’s auto component sectorcontributes 2.3% to GDP and employs 1.5 million people directly.
The sector grew at a CAGR of 8.63% from FY16-FY24.
Exportsreached US$ 21.2 billion in FY24 and are projected to hit US$ 30 billion by 2026.
The government is actively promoting electric mobility and advanced automotive technologies.
Introduction
Launched in 2014, the Make in India initiative has significantly transformed India’s automobile industry, fostering domestic car production and accelerating electric vehicle (EV) manufacturing. Over the past decade, policy reforms, fiscal incentives, and infrastructure development have positioned India as a key global automotive hub. The sector has attracted substantial investments, spurred innovation, and increased localization, contributing to economic growth and sustainability.
The Indian auto industry is one of the fastest-growing sectors. It embarked on a new journey in 1991 with the de-licensing of the sector and subsequent opening up for 100 percent FDI through the ‘automatic route’. Since then, almost all the global majors have set up their manufacturing facilities in India, taking the level of production of vehicles from 2 million in 1991-92 to around 28 million in 2023-24.
The turnover of the Indian automotive industry is about USD 240 billion (20 Lakh Crore), which translates into a large contribution to the country’s economy and manufacturing sector. As per the Annual Report 2024-25 of the Ministry of Heavy Industries, around 30 million jobs (Direct: 4.2 million and Indirect: 26.5 million) are supported by the Indian Auto Industry. Indian Automotive Industry exported vehicles and auto components amounting to about USD 35 billion. In terms of global standing, India is the largest manufacturer of three-wheelers, among the top 2 manufacturers of two-wheelers in the world, the top 4 manufacturers of passenger vehicles, and the top 5 manufacturers of commercial vehicles in the world.
Auto Components Industry in India
The auto component sector is one of the key pillars of India’s manufacturing industry, supplying critical parts and systems to domestic vehicle manufacturers and exporting to major global markets. The industry covers a broad spectrum of products, including engine parts, transmission systems, braking systems, electrical and electronics components, body and chassis parts, and more. India has become a preferred destination for auto component manufacturing due to its cost competitiveness, skilled workforce, and strong policy support. The auto component sector is expected to reach the $100 billion export target by 2030 making the sector one of the largest job creators in the country.
Overview of the Auto Components Industry
Contribution to GDP
2.3%
Direct Employment
1.5 million people
Industry Turnover (FY24)
Rs. 6.14 lakh crore (US$ 74.1 billion)
Domestic OEM Supply Share
54%
Export Share
18%
CAGR (FY16-FY24)
8.63%
Export Value (FY24)
US$ 21.2 billion
Projected Exports (2026)
US$ 30 billion
India’s auto component sector contributes 2.3% to India’s GDP, directly employing over 1.5 million people. The sector’s turnover in FY24 was Rs. 6.14 lakh crore (US$ 74.1 billion), with domestic OEM supplies making up 54%, and exports contributing 18%. Over FY16-FY24, the industry grew at a CAGR of 8.63%. In FY24, exports reached US$ 21.2 billion, with a trade surplus of US$ 300 million, and are projected to hit US$ 30 billion by 2026.
The Indian auto components industryexportsover 25% of its production annually. By FY28, the Indian auto industry aims to invest US$ 7 billion to boost the localisation of advanced components like electric motors and automatic transmissions by reducing imports and leveraging the “China Plus One” trend. In 2023, the auto component industry achieved a 5.8% reduction in imports over two years. The majority of the components sold to Original Equipment Manufacturers (OEMs) are engine components (26%), body/chassis/BIW (14%), suspension and braking (15%), drive transmission and steering (13%), and electricals & electronics (11%). Major exports are to Europe (US$ 6.89 billion), followed by North America (US$ 6.19 billion) and Asia (US$ 5.15 billion).
Growth in Domestic Automobile Production
The automobile sector contributes approximately 6%to India’s national GDP, with exports reaching 4.5 million units across all categories in FY 2023-24, including 6.72 million passenger vehicles and 3.45 million 2-wheelers. Global automotive companies like Skoda Auto Volkswagen India exporting 30% of their production and Maruti Suzuki exporting around 2.8 lakh units annually, exemplify this trend.
The sector has attracted$36 billioninForeign Direct Investment (FDI)over the past four years, highlighting India’sgrowing prominencein theglobal automotive landscape. Major international players are making substantial commitments, withHyundaiplanning aUSD 4 billion(INR 33,200 Crore) expansion, whileMercedes-Benzhas pledgedUSD 360 million(INR 3,000 Crore). Recently,Toyotaannounced aUSD 2.3 billion(INR 20,000 Crore) investment to further increase its capacity.
Electric Vehicle (EV) Manufacturing Boom
The country is also advancing in sustainable mobility, with 4.4 million Electric Vehicles (EV) registered by August 2024, including 9.5 lakh in the first eight months of 2024, achieving a 6.6% market penetration. To support this growth, the government has implemented initiatives such as the Production Linked Incentive (PLI)Scheme for Advanced Chemistry Cell (ACC) battery storage. In the 2024-25 Budget, the government allocated INR 2,671.33 crore under the FAMEscheme and proposed the exemption of customs duties from the import of critical minerals required for EV cell components manufacturing.
Additionally, in March 2024, the Electric Mobility Promotion Scheme (EMPS) was launched with an INR 500 Crore outlay for four months, specifically targeting support for the two and three-wheeler segments to expedite the transition to electric vehicles. These initiatives align with the recent discovery of lithium deposits in Jammu & Kashmir, positioning India to become a key player in the global battery manufacturing industry in the coming years. The Indian EV sector is likewise developing quickly and is predicted to record a growth of USD 113.99 billion in 2029.
As per the inputs provided by Society of Indian Automobile Manufacturers (SIAM), the total annual production of Electric Vehicles (EVs) in India during the last five years, year-wise is as given below:
The Ministry of Heavy Industries has formulated the following schemes to promote electric vehicles (EVs) and to address the various challenges faced in adoption of electric mobility including availability and accessibility of charging stations in the country:
Faster Adoption and Manufacturing of (Hybrid &) Electric Vehicles in India (FAME India) Scheme Phase-II: The Government implemented this scheme for a period of five years from 1 April2019 with a total budgetary support of INR 11,500 Crore. The scheme incentivised e-2Ws, e-3Ws, e-4Ws, e-buses and EV public charging stations. The Department of Heavy Industries has also sanctioned 2636 charging stations in 62 cities across 24 States/UTs under phase II. State-wise allocation of these charging stations is as follows:
Production Linked Incentive (PLI) Scheme for Automobile and Auto Component Industry in India (PLI-Auto): The Government notified this scheme on 23 September 2021 for Automobile and Auto Component Industry in India for enhancing India’s manufacturing capabilities for Advanced Automotive Technology (AAT) products with a budgetary outlay of INR 25,938 Crore. The scheme proposes financial incentives to boost domestic manufacturing of AAT products with minimum 50% Domestic Value Addition (DVA) and attract investments in the automotive manufacturing value chain.
Feature
Details
Budgetary Outlay
Rs. 25,938 crore
Target Years
FY 2022-23 to FY 2026-27
Domestic Value Addition
Minimum 50%
Focus
Advanced Automotive Technology (AAT) products
Targeted Technologies
Electric Vehicles (EVs) and Hydrogen Fuel-Cell Components
Incentives for EVs and Hydrogen Fuel-Cell Components
13% – 18%
Incentives for AAT components
8% – 13%
Investment Attraction
Global OEMs
Eligibility
Both domestic and export sales
PLI Scheme for Advanced Chemistry Cell (ACC): The Government on 12 May 2021 approved PLI Scheme for manufacturing of ACC in the country with a budgetary outlay of INR 18,100 Crore. The scheme aims to establish a competitive domestic manufacturing ecosystem for 50 GWh of ACC batteries.
PM Electric Drive Revolution in Innovative Vehicle Enhancement (PM E-DRIVE)Scheme: This scheme with an outlay of INR 10,900 Crore was notified on 29 September 2024. It is a two-year scheme which aims to support electric vehicles including e-2W, e-3W, e-Trucks, e-buses, e-Ambulances, EV public charging stations and upgradation of vehicle testing agencies.
PM e-Bus Sewa-Payment Security Mechanism (PSM) Scheme: This Scheme notified on 28 October 2024, has an outlay of INR 3,435.33 Crore and aims to support deployment of more than 38,000 electric buses. The objective of scheme is to provide payment security to e-bus operators in case of default by Public Transport Authorities (PTAs).
Scheme for Promotion of Manufacturing of Electric Passenger Cars in India(SMEC) was notified on 15 March 2024 to promote the manufacturing of electric cars in India. This requires applicants to invest a minimum of INR 4,150 crore and to achieve a minimum DVA of 25% at the end of the third year and DVA of 50% at the end of the fifth year.
Measures taken by other Ministries include the following initiatives:
Ministry of Power has issued guidelines and standards for EV Charging Infrastructure titled, “Guidelines for Installation and Operation of Electric Vehicle Charging Infrastructure-2024” on 17 September 2024. These revised guidelines outline standards and protocols to create a connected & interoperable EV charging infrastructure network in the country.
Ministry of Finance has reduced GST on EVs from 12% to 5%.
Ministry of Road Transport & Highways (MoRTH) announced that the battery-operated vehicles will be given green plates and be exempted from permit requirements.
Ministry of Housing and Urban Affairs has amended the Model Building Bye-Laws, mandating the inclusion of charging stations in private and commercial buildings.
Conclusion
The Make in India initiative has driven unprecedented growth in India’s automobile sector and Indi’s auto component sector, significantly boosting domestic car production and EV manufacturing. Through sustained policy support, investment influx, and technological advancements, India is on track to becoming a global leader in automotive and electric mobility and achieving greater self-reliance in the automotive sector.
The DBIM framework strengthens the government’s vision of ‘Minimum Government, Maximum Governance: Jayant Chaudhary MSDE Launches DBIM-Compliant Website
Posted On: 25 MAR 2025 5:29PM by PIB Delhi
In a significant step toward strengthening India’s digital governance ecosystem, the Ministry of Skill Development and Entrepreneurship (MSDE) today launched its DBIM-compliant website, developed in alignment with the Digital Brand Identity Manual (DBIM) Version 3.0 introduced by the Ministry of Electronics and Information Technology (MeitY).
Launching the revamped website, Sh. Jayant Chaudhary the Minister of State (Independent Charge), MSDE, said: “The DBIM framework strengthens the government’s vision of ‘Minimum Government, Maximum Governance’ by creating a unified and citizen-centric digital ecosystem. As India’s digital economy expands, a standardized and seamless service delivery model is crucial. Our Ministry’s website, aligned with DBIM 3.0, ensures that skilling opportunities are more accessible, inclusive, and efficient for every citizen.” Sh. Chaudhary congratulated the MSDE IT team and NIC for their efforts in making this possible. Further he encouraged all stakeholders to explore the website and leverage its enhanced features for seamless access to skilling initiatives and resources.
The newly launched website enhances accessibility, uniformity, and ease of navigation for users, featuring AI-powered search, multi-language support through Bhashini, persona-led navigation, and centralized content management. With its three-click approach, it ensures citizens can seamlessly access essential services and skilling resources.
The MSDE website serves as a one-stop digital hub showcasing all flagship schemes and initiatives of the Ministry, including Skill India Mission, Pradhan Mantri Kaushal Vikas Yojana (PMKVY), National Apprenticeship Promotion Scheme (NAPS), and more. Each initiative is seamlessly linked to its respective dashboard, portals, and resources, ensuring real-time access to data, performance metrics, and impact stories. The website’s integrated design enhances transparency and enables stakeholders, industries, and citizens to easily explore skilling opportunities, track progress, and engage with government programs more efficiently.
The DBIM framework, introduced by MeitY, ensures a consistent digital presence across all government ministries and platforms, fostering a seamless, integrated, and transparent governance approach. MSDE is among the first five ministries to transition to this new system, reflecting its commitment to leveraging technology for efficient public service delivery.
The Minister further urged all MSDE-operated portals to adopt DBIM standards soon, ensuring standardized governance across all digital platforms under the Skill India Mission.
For more details, visit the new MSDE website: www.msde.gov.in
Ministry of Ayush has taken multiple initiatives towards integration of Ayush systems of medicine with Allopathic system
Posted On: 25 MAR 2025 6:11PM by PIB Delhi
The Ministry of Ayush has taken multiple initiatives towards integration of Ayush systems of medicine including Ayurveda with Allopathic system:
The Ayush Vertical under Directorate General of Health Services (DGHS), established by the Ministry of Ayush and Ministry of Health and Family Welfare (MoH&FW), serves as a dedicated institutional mechanism for planning, monitoring, and supervising Ayush-specific public health programs. This vertical provides technical support to both Ministries in developing strategies for public health, healthcare, Ayush education, and training.
The Ministry of Ayush and MoH&FW have jointly established Integrated Ayush Departments in Central Government Hospitals to promote integrative healthcare. As part of this initiative, Department of Integrative Medicine has been set up and is operational at Vardhman Mahavir Medical College & Safdarjung Hospital and Lady Hardinge Medical College, New Delhi through All India Institute of Ayurveda (AIIA), New Delhi and Central Ayurveda Research Institute (CARI), Punjabi Bagh, New Delhi respectively. No separate funding is allocated for establishing these centres.
An Advisory committee was constituted under the chairpersonship of Dr. V.K. Paul, Member (Health), NITI Aayog to study the existing knowledge and efficacy of different models of Integrative Medicine and its benefits at large and to propose a framework of comprehensive Integrative Health Policy.
Government of India has adopted a strategy of Co-location of AYUSH facilities at Primary Health Centres (PHCs), Community Health Centres (CHCs) and District Hospitals (DHs), thus enabling the choice to the patients for different systems of medicines under a single window. The engagement of AYUSH doctors/ paramedics and their training is supported by the MoH&FW under National Health Mission (NHM), while the support for AYUSH infrastructure, equipment/ furniture and medicines are provided by the Ministry of Ayush under National AYUSH Mission (NAM) as shared responsibilities.
The Central Council for Research in Ayurvedic Sciences (CCRAS) has undertaken research studies such as Operational study to explore the feasibility of integrating Ayurveda with modern system of medicine in a tertiary care hospital (Safdarjung Hospital New Delhi) for the management of Osteoarthritis (Knee), Feasibility of introducing the Indian System of Medicine (Ayurveda) in the National Reproductive and Child Health services at the Primary Health Care (PHC) level in Himachal Pradesh and Integration of AYUSH systems in the National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases & Stroke (NPCDCS) and Feasibility of introducing Ayurveda Intervention in Reproductive and Child Health (RCH) in PHCs of the Selected district (Gadchiroli) of Maharashtra (Effectiveness of Ayurvedic intervention for Ante-Natal care (Garbhini Paricharya) at Primary Health Care level: A Multi Centre Operational Study). Details of the collaborative projects by the Council in the last five years are given in AnnexureI.
Further, Indian Council of Medical Research (ICMR) and CCRAS has taken an initiative to set up Ayush-ICMR Advanced Centre for Integrative Health Research (AI-ACIHR), at All India Institute of Medical Sciences (AIIMS) to conduct research on identified areas focusing on integrative healthcare under Extra Mural research Scheme of ICMR. Under this program, four research areas in four AIIMS have been identified, which are as follows:
AIIMS Delhi:
Advanced Centre for Integrative Health Research in Gastro-intestinal Disorders
Advanced Centre for Integrative Health Research in Women and Child Health
AIIMS Jodhpur: Advanced Centre for Integrative Health Research in Geriatric Health
AIIMS Nagpur: Advanced Centre for Integrative Health Research in Cancer Care
AIIMS Rishikesh: Advanced Centre for Integrative Health Research in Geriatric Health.
In All India Institute of Ayurveda (AIIA), New Delhi, integrative medical services are available under, Centre for Integrative Cancer Therapy, Centre for Integrative Dentistry, Centre for Integrative Critical Care & Emergency Medicine, Centre for Integrative Orthopedics, Centre for Integrative Dietetics and Nutrition and Causality OPD Section. Integrated services are also provided through Satellite Clinical Services Units established at Integrative Medical Services Unit at Safdarjung Hospital, New Delhi, Integrative Medical Services Unit AIIMS Jhajjar and Centre for Integrative Oncology at National Cancer Institute – AIIMS, Jhajjar.
Institute of Teaching and Research in Ayurveda (ITRA), conducts integrated research and also has visiting allopathic doctors for consultation.
The Ministry of Ayush has been implementing the Central Sector Scheme namely Ayurswasthya Yojana since 2021-22. The Scheme has 02 components viz. (i) Ayush & public health (PHI) component and (ii) Upgradation of facilities to the centre of excellence. Under the Centre of Excellence, financial assistance is provided to support creative and innovative proposals of prestigious organizations with well-established buildings and infrastructure and wish to work for Ayush systems to the level of Centre of Excellence. Nine organizations of National repute have been funded under the Centre of Excellence component of Ayurswasthya Yojana under the activity-based/research-based Centre of Excellence for research and development to integrate the knowledge of Ayurveda with the modern system of medicine. Details of organizations are given at Annexure II.
Annexure I
LIST OF COLLABORATIVE PROJECTS OF LAST FIVE YEARS 2020-21 TO 2024-25
COMPLETED PROJECTS
S.
No.
Name of Project
Name of the Collaborating Institutes
1.
Evaluation of Add on Efficacy & Safety of an Ayurvedic coded Formulation in the management of Dengue Fever & Prevention of its complications – A Double Blind Clinical Study
National Institute of Traditional Medicine, Belagavi, KLE University’s Department of Integrative Medicine, Kolar.
2.
A Randomized Placebo Controlled Prospective Phase II Clinical Study of an Ayurvedic Coded Drug ‘AYUSH-D’ on Glycemic control in Pre- Diabetic Subjects
Central Ayurveda Research Institute, Bengaluru
AIIMS, New Delhi
RRA Poddar Medical College, Mumbai
KLEU’s Shri BMK Ayurveda Mahavidyalaya, Belgavi
3.
A Randomized Placebo Controlled Phase II Clinical Study of an Ayurvedic Coded Drug ‘AYUSH-D’ in the management of Type 2 Diabetes Mellitus as add on Therapy to Metformin
Central Ayurveda Research Institute, Bengaluru
AIIMS, New Delhi
RRA Poddar Medical College, Mumbai
Rajiv Gandhi PG Govt Ayurveda College, Paprola
4.
Multi-centric Collaborative Double Blind study on clinical evaluation of AYUSH-SL in chronic Filarial Lymphoedema in patients receiving mass drug administration Multi-centric Collaborative Double Blind study on clinical evaluation of AYUSH-SL in chronic Filarial Lymphoedema in patients receiving mass drug administration
Calcutta School of Tropical Medicine (CSTM) in collaboration with CARI, Kolkata
Central Ayurveda Research Institute, Bhubaneswar
Regional Ayurveda Research Institute, Vijayawada
5.
Feasibility of introducing Ayurveda intervention in Reproductive and Child Health
30 PHCs of Gadchiroli District of Maharashtra
(RCH) in PHCs of selected district (Gadchiroli) of Maharashtra (Effectiveness of Ayurvedic Intervention for Ante-Natal care (Garbhini Paricharya) at Primary Health Care level: A Multi Centre Operational Study)
6.
Randomized control study to evaluate the efficacy of Ayush CCT and Rajyoga Meditation versus conventional treatment on clinical recovery and post-operative outcomes following elective adult cardiothoracic surgeries
AIIMS, New Delhi
7.
Clinical evaluation of the efficacy of “Ayush- SS Granules” in exclusively breast feeding mothers with Insufficient Lactation (Stanyalpata)-A Randomized double blind placebo control Trial”
Vardhman Mahavir Medical College & Safdarjang Hospital, New Delhi
8.
A comparative clinical study of Ayush LND a coded Ayurvedic formulation in the management of Asrigdara (Abnormal Uterine Bleeding)
Regional Ayurveda Research Institute,, Nagpur
Govt. Medical College, Nagpur
9.
A Randomized controlled trial to evaluate the efficacy of Marma therapy in Lumbar disc Herniation with Radiculopathy.
Uttrakhand Ayurved University, Dehradun
10.
Efficacy of Ayurveda nutritional supplements and Yoga protocol in the prevention and reduction of the severity of Acute Mountain Sickness: an open-label randomized controlled study
2118 field hospitals, Nimu/Leh under the AFMS, Northern Command of Indian Army
11.
A pilot study to assess the effect of intranasal oil instillation (Pratimarsha Nasya) on nasal barrier function among healthy individuals
Dr D Y Patil Vidyapeeth, Pune
12.
Prospective double blind randomized controlled clinical study on Ayurvedic intervention (Sarpagandha Mishran) vs. Amlodipine in the management of stage-I Primary Hypertension
AIIMS Delhi
13.
Randomized double blind placebo controlled clinical study Ayurvedic coded drug AYUSH-A in the management of Bronchial Asthma (Tamaka Shwasa)
AIIMS Delhi
14.
Study the physiological basis and gut bacterial modulation induced by Virechana Purgation therapy in the healthy adults: A prospective longitudinal study.
Institute of Liver and Biliary Sciences, Delhi
15.
Morbidity and Healthcare-seeking behaviour of
Directorate General Armed Force
the patients visiting the Ayurveda healthcare facilities of the DGAFMS Hospitals: A multicentre cross-sectional survey study
Medical Services- facilities
16.
A Randomized Controlled Study to Assess the Effect of Marsha Nasya Karma in Motor, Sensory, Memory and Cognitive Parameters elicited through f – MRI in Apparently Healthy Individuals.
Amrita Institute of Medical Sciences, Cochin, Kerala
17.
Evaluation of Ayush-GMH in the subjects of mild to moderate Non alcoholic fatty liver disease (NAFLD)-A double blind randomized control clinical study
KLE’s Dr. Prabhakar Kore Hospital & Medical Research Centre, Belagavi ICMR – National Institute of Traditional Medicine, Belegavi
18.
A randomized trial to evaluate the efficacy of multimodal Ayurveda interventions in Jannu Sandhigatavata (Primary Knee – osteoarthritis)
AIIMS Delhi
19.
Clinical evaluation of Ayurvedic management in Allergic Rhinitis- A Randomized controlled Trial
Vardhman Mahavir Medical College & Safdarjang Hospital, New Delhi
ONGOING PROJECTS
S.
No.
Name of Project
Name of the Collaborating Institutes
1.
A phase II trial to study efficacy, toxicity and imunomodulatory effect of Carctol-S in high grade serous epithelial ovarian cancer at first serological relapse collaborative project.
Tata Memorial Hospital ACTREC Mumbai & Central Ayurveda Research Institute, Mumbai
2.
Evaluation of Hepatoprotective activity of PTK as an add on therapy in the patients of Tuberculosis on ATT – A double blind randomized control clinical study
KLE’s Dr. Prabhakar Kore Hospital & Medical Research Centre, Belagavi
3.
Evaluating the efficacy of Ayurvedic intervention as add on to conventional treatment and explore the interaction of epigenetics, neuro/gut biomarkers and neuroimaging in pediatric ADHD (Attention Deficit Hyperacidity Disorder)
National Institute of Mental Health and Neurosciences, Bengaluru
4.
Double blind randomized placebo controlled multicentric clinical trial of Ayush M-3 in the management of Migraine.
National Institute of Mental Health and Neurosciences, Bengaluru
5.
Ayurveda therapeutic regiman as on Add-on
to optimized conventional management of Parkinson’s disease: an RCT for assessment
National Institute of Mental Health and Neurosciences, Bengaluru
of clinical Cortical excitability neuroimmune and Autonomic function parameters.
6.
Efficacy and safety of Ayurveda Formulation Trikatu as add on to standard care in Dyslipidemia – a randomized controlled trial
AIIMS, Bhubaneswar
7.
Efficacy of Ayurveda regimen (mild purgation and internal oleation) in comparison with Allopathic regimen (Letrozole) along with Yoga module in the management of unexplained and anovulatory female infertility: A RCT
IIT, Mandi
8.
Topical Oil Pooling (Karnapurana) with Kshirabala Taila and supple mentation of Ashwagandha churna (TOPMAC) in presbycusis – An exploratory randomized controlled trial
Institute for Communicative and Cognitive Neurosciences(ICCONS), Shoranur, Kerela
9.
Prospective, Randomized, Open-Label, Blinded End Point exploratory clinical study to evaluate the efficacy and safety of Ayurvedic regimen as an adjunct to Hydroxyurea in the management of Sickle cell disease.
AIIMS, Bhopal
10.
A multi-center study to assess the treatment adherence & tolerability of Ayush SR in Generalized Anxiety Disorder (GAD)
Shri B.M. Kankanawadi Ayurveda Mahavidyalaya, Belgavi; Vaidyaratnam PS Varier Ayurveda College, Kotakkal; Sri Sri College of Ayurvedic Science and Research, Bengaluru; Adichunchanagiri Ayurvedic Medical College, Bengaluru
11.
Impact of Mukta Shukti Bhasma and Saubhagya Shunti in reversal of bone mineral density among Lactating women consuming traditional diet foods in Maharashtra: A randomized Controlled preliminary clinical study
ICMR-National Institute for Research in Reproductive and Child Health, Mumbai
12.
Efficacy of Ayurveda interventions (Hridyarnava Rasa and Harityakyadi yoga) as an add-on to standard care in Stable Coronary Artery Disease (CAD) assessed through Global Longitudinal Strain Imaging Technique (GLSIT) – A Randomized Controlled Trial.
Ayurvedic Cardiac Rehabilitation Centre, Madhavbaugh, Pune
13.
Prospective double blind randomized controlled clinical study on Ayurvedic intervention (Pushkar guggulu & Haritaki churna) in the management of stable coronary artery disease.
Safdarjung Hospital, New Delhi
14.
A randomized double blind placebo control clinical study to evaluate the immunomodulatory effect of Swarnaprashan in moderately malnourished children.
Sanjiv Gandhi Post Graduate Institute of Medical Sciences, Lucknow
15.
Randomized controlled trial of Anshumati Ksheer Paka in hypertension induced left ventricular hypertrophy
Safdarjung Hospital, New Delhi
16.
Anemia control among adolescent girls through Ayurveda interventions in the five districts under Mission Utkarsh
All India Institute of Ayurveda, New Delhi;
National Institute of Ayurveda, Jaipur, Public Health Foundation India’s IIPH- Delhi
17.
An exploratory series of n of 1 responder restricted study of Ayurveda regimen on quality of life among elderly population in Ballabgarh district of Haryana- A community based study.
AIIMS, Ballabhgarh
ANNEXURE II
NINE ORGANIZATIONS OF NATIONAL REPUTE FUNDED UNDER CENTRE OF EXCELLENCE COMPONENT OF AYURSWASTHYA SCHEMETO INTEGRATE KNOWLEDGE OF AYURVEDA WITH MODERN SYSTEM OF MEDICINE AYURSWASTHYA SCHEME:
S.
No.
Name of the Organization
State
Project Name
Fund Released (Amount in Crore)
2022-23
2023-24
2024-25
1.
Tata Memorial Centre, (TMC) Mumbai
Maharashtra
Centre of
Excellence for
Discovery and Development of AYUSH
Medicine for Cancer Care
–
2.00
1.62
2.
Central Drug Research Institute (CDRI),
Lucknow
Uttar Pradesh
Center of
Excellence for Fundamental and Translation Research in
Ayurveda at Central Drug Research Institute
–
2.00
1.99
3.
Jawaharlal Nehru University, (JNU) New Delhi
Delhi
Functional-based CoE on Ayurveda
and Systems Medicine
–
1.01
2.44
4.
Indian Institute of Technology (IIT) Delhi
Delhi
Centre of
Excellence in Sustainable Ayush for Advanced technological solutions, startup support and net zero sustainable solutions for
Rasausadhies
–
2.00
1.14
5.
Indian Institute of Science (IISC) Bengaluru
Karnataka
Centre of
Excellence in
Diabetes and Metabolic Disorders
–
2.00
1.82
6.
Centre for
Delhi
Centre of
2.05
2.04
–
Integrative Medicine and Research (CIMR), AIIMS
New Delhi
Excellence for
Yoga &
Ayurveda
7.
National Institute of Mental Health and Neurosciences (NIMHANS),
Bangalore
Karnataka
Centre of
Excellence in Ayush Research
0.85
0.37
–
8.
Institute of Liver and Biliary Sciences (ILBS)
Delhi
Effects of Indian Foods and Ayurvedic drugs
on healthy and diseases Liver
2.61
–
–
9.
Indian Institute of Technology, (IIT) Jodhpur
Rajasthan
Centre of
Excellence in AYURTech for Integrative Precision Health and Medicine
–
4.00
–
Total
5.51
15.42
9.01
This information was given by Union Minister of State (I/C) for Ayush, Shri Prataprao Jadhav in a written reply in Rajya Sabha today.